PRESS RELEASE published on 10/01/2025 at 17:49, 10 months 14 days ago HBM Healthcare Investments reports strong quarterly results – NAV rises by 16.4 per cent in the second quarter of the 2025/2026 financial year HBM Healthcare Investments reports a 16.4% increase in NAV in the second quarter of the 2025/2026 financial year, expects positive momentum from investments in private and listed companies Financial Results HBM Healthcare Investments Investment Performance NAV Increase Clinical Trial Results
PRESS RELEASE published on 10/01/2025 at 17:47, 10 months 14 days ago Key Figures 30.09.2025 HBM Healthcare Investments AG reports key performance figures as of 30.09.2025 in CHF. NAV at 251.78 CHF, Share Price at 180.80 CHF, Total Net Assets 1'682 million CHF HBM Healthcare Investments AG Key Figures CHF Performance Figures 30.09.2025
BRIEF published on 09/29/2025 at 10:39, 10 months 17 days ago Genmab to Acquire Merus for USD 8 Billion Acquisition Investment Oncology Genmab Merus
PRESS RELEASE published on 09/29/2025 at 10:34, 10 months 17 days ago Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash Genmab to acquire HBM portfolio company Merus for USD 8 billion in cash. Merus is known for its innovative oncology therapies. The transaction with Genmab represents a 41% premium on the closing price Acquisition Oncology HBM Healthcare Genmab Merus
BRIEF published on 09/16/2025 at 17:52, 10 months 29 days ago HBM Healthcare Investments AG Reports Modest Growth in September 2025 Financial Results Net Asset Value Investment Performance Share Price HBM Healthcare
PRESS RELEASE published on 09/16/2025 at 17:47, 10 months 29 days ago Key Figures 15.09.2025 HBM Healthcare Investments AG reports key figures for 15.09.2025 in CHF. NAV at 245.43, Share Price at 178.00, and Total Net Assets at 1,641 million. Performance percentages shown Performance HBM Healthcare Investments AG Key Figures CHF 15.09.2025
BRIEF published on 09/10/2025 at 08:40, 11 months 6 days ago Swixx BioPharma and Lundbeck Forge Multi-Regional CNS Partnership Emerging Markets Swixx BioPharma Healthcare Investments Lundbeck CNS Partnership
PRESS RELEASE published on 09/10/2025 at 08:35, 11 months 6 days ago HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership HBM Healthcare Investments announces partnership between Swixx BioPharma, Lundbeck for CNS therapies in South-East Europe, Turkey and Latin America Partnership HBM Healthcare Investments CNS Therapies Swixx BioPharma Lundbeck
BRIEF published on 09/01/2025 at 17:52, 11 months 14 days ago HBM Healthcare Investments AG Reports August 2025 Key Figures Performance Share Price NAV Swiss Exchange HBM Healthcare
PRESS RELEASE published on 09/01/2025 at 17:47, 11 months 14 days ago Key Figures 31.08.2025 HBM Healthcare Investments AG reports key financial figures for August 2025, with a NAV of 240.62 CHF and Total Net Assets of 1,610 million CHF. Share price increased by 4.0% HBM Healthcare Investments Financial Figures Share Price NAV August 2025
Published on 08/15/2026 at 00:15, 1 day 12 hours ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 1 day 12 hours ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:00, 1 day 13 hours ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/16/2026 at 09:45, 2 hours 59 minutes ago Ragnarok Zero: Global Set to Officially Launch on August 18
Published on 08/16/2026 at 06:15, 6 hours 29 minutes ago Garvee Spotlights Home & Garden Essentials for the Late-Summer to Early-Autumn Transition
Published on 08/15/2026 at 15:05, 21 hours 39 minutes ago Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 1 day 4 hours ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/10/2026 at 18:00, 5 days 18 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 6 days ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 6 days 1 hour ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 6 days 3 hours ago Number of shares and voting rights - July 2026 (In French only)
